EPR Issue 2 includes articles on the future of cell and gene therapy, the potential of AAV gene therapies, NMR relaxometry and more…
Included in this issue of European Pharmaceutical Review:
FOREWORD
New quality requirements for tobacco products
David Elder, David P Elder Consultancy
QA/QC MASS SPECTROMETRY
The benefits of mass spectrometry for expediting biologics to patients
Ian Anderson, Mostafa Zarei and Qifeng Zhang, Lonza
IN-DEPTH FOCUS: Bioprocessing/Bioproduction
Realising the potential of AAV gene therapies
Rajiv Vaidya, Andelyn Biosciences
What gene therapy manufacturers can gain from collaboration
Neil Almstead, PTC Therapeutics
DATA INTEGRITY
Innovating pharma at the edge
Greg Hookings, Stratus Technologies
QA/QC CHROMATOGRAPHY
Digitalising HPLC methods: the path to interoperability
Birthe Nielsen, The Pistoia Alliance
REGULATORY INSIGHT
Preparing for stricter standards on substances of human origin
Ulf Grundmann, Elisabeth Kohoutek and Lara Sophie Hucklenbroich, King & Spalding
GUIDE TO: TESTING
Exploring low endotoxin recovery in drug products
Chiara Celli, Marco Mingolla and Fabrizio Lecce, Institute of Biomedical Research Antoine Marxer
SUPPLY CHAIN
Evaluating NMR relaxometry for antibody identification
Gregory Webster, AbbVie
IN-DEPTH FOCUS: DRUG DEVELOPMENT
Re-engineering proteins to develop novel immunotherapies
Jessicca Rege, Alkermes
Regenerative potential: cell‑based therapies for heart failure
Ibon Garitaonandia, CellProthera
Download Now
Digital Journal
Topics
- AbbVie
- Advanced therapies manufacturing
- Alkermes
- Analytical and bioanalysis
- Andelyn Biosciences
- Associates of Cape Cod International
- Big Pharma
- Biologics formulation and stability
- Bioprocessing and biomanufacturing
- CellProthera
- Chiara Celli (Institute of Biomedical Research Antoine Marxer)
- Clinical Development
- Data Analysis
- Data integrity
- Dave Elder (David P Elder Consultancy)
- David P Elder Consultancy
- Drug Development
- Endotoxin
- Endotoxin Detection
- Environmental Monitoring
- Fabrizio Lecce (Institute of Biomedical Research Antoine Marxer)
- Formulation and drug delivery
- Greg Hookings (Stratus Technologies)
- Gregory Webster (AbbVie)
- HPLC
- Ibon Garitaonandi (CellProthera)
- Immunotherapy
- Impurities, contaminants and nitrosamines
- Institute of Biomedical Research Antoine Marxer
- Jessicca Rege (Alkermes)
- Legal
- Lonza
- Marco Mingolla (Institute of Biomedical Research Antoine Marxer)
- Neil Almstead (PTC Therapeutic)s
- Pharmacovigilance and safety oversight
- Production
- PTC Therapeutics
- Quality, microbiology and contamination control
- Rajiv Vaidya (Andelyn Biosciences)
- rapid endotoxin testing
- Raw materials and supply chain (bioprocess)
- Regulation and compliance
- Spectroscopy and imaging
- Stratus Technologies
- Technology
- The Pistoia Alliance
- Therapeutics
